Nikki Cheng, PhDAssistant Professor of Pathology and Laboratory Medicine
Division of Cancer and Developmental Biology
PhD: Vanderbilt University 2002
Post-doctoral: Vanderbilt University, 2003-2008
Office Telephone: 913-945-6773
Laboratory Telephone: 913-945-6772
Email: ncheng @ kumc.edu
Publications: Click here for list of publications from PubMed
Ph.D. students are welcome. Contact me for more info.
My
laboratory is interested in investigating the functions of stromal
fibroblasts in the tumor microenvironment during breast cancer
progression. Fibroblasts are a major cellular component of the
tumor microenvironment and influence cancer cell behavior directly
and indirectly through secretion of soluble factors, including
growth regulators and angiogenic factors. While genetic alterations
in breast fibroblasts may exert pro-tumorigenic effects, little
is known of the cellular and molecular signals that regulate
fibroblast functions in the tumor microenvironment.
Studies in my laboratory suggest that fibroblasts may interact with breast cancer cells to regulate cancer cell motility and invasion through chemokines signaling. Chemokines are a family of soluble proteins which signal to seven transmembrane G coupled receptors and regulate immune cell recruitment during inflammatory responses and defense against foreign pathogens. Studies in our laboratory indicate that CCL2 and CXCL1 chemokine signaling may also regulate fibroblast interactions with other cell types in the microenvironment to promote tumor progression. Using multiple approaches including mouse models of cancer, molecular biology, biochemistry and cell culture systems, we are interested in:
Ultimately, we are interested in understanding the functions of stromal cells in the tumor microenvironment and the impact of the tumor microenvironment on metastatic spread. By identifying and understanding the molecular signals that create a tumor permissive environment, these studies may contribute to identifying new molecular targets for therapy and to developing improved methods for diagnosing and treating metastatic breast cancer.
Nikki Cheng, PhD
University of Kansas Medical Center
Department of Pathology and Laboratory Medicine
3901 Rainbow Blvd
Mailstop 3045
Kansas City, KS 66160
Lab: Lied 3001
Office: 913-945-6773
Lab: 913-945-6772
Fax: 913-945-6650
Iman Jokar, MD, research assistant
ijokar@kumc.edu
Diana Lambert, B.Sci, research assistant
dlambert@kumc.edu
Wei Bin Fang, Ph.D, postdoctoral fellow
wfang@kumc.edu
An Zou, graduate student
azou@kumc.edu
